Validated total solution for newborn heel-prick screening of metabolic diseases using mass spectrometry for multiple laboratories

Summary

The tender concerns the supply, implementation and maintenance of a validated total solution for newborn heel-prick screening for metabolic diseases using mass spectrometry. The solution includes equipment, software, reagents and preventive, corrective and adaptive maintenance for three screening laboratories. Under the reagent-rental model, the supplier remains the owner of the equipment and is fully responsible for supplying, implementing and continuously making the solution available. The procurement also includes a mass spectrometer or liquid chromatography system for the RIVM-GZB reference laboratory, including hardware, software and maintenance. The estimated value is EUR 25,000,000. The planned contract term is 5 years, with up to 3 extensions. Tenders must be submitted electronically by 10 November 2026 at 11:00, and must remain valid for 120 days. The precise technical and qualification requirements must be checked in the tender documents.